comparemela.com

Latest Breaking News On - Vistagen therapeutics - Page 9 : comparemela.com

Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday s Mid-Day Session - a k a Brands Holding (NYSE:AKA), Akumin (NASDAQ:AKU)

Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) shares jumped 58% to $1.88 after the company reported better-than-expected second-quarter financial results.

Brendan hoffmanApplovin corporationRaymond jamesMissfresh limitedMatinas biopharma holdings incCarrols restaurant group incVistagen therapeutics incKrispy kreme incUnited insurance holdings corpSkin sciences incCleanspark incGinkgo bioworks holdings incBruush oral care incInnoviz technologies ltdLife sciences corpEntravision communications corporation

Vistagen Therapeutics (NASDAQ:VTGN) Upgraded to Buy at Maxim Group

Maxim Group upgraded shares of Vistagen Therapeutics (NASDAQ:VTGN – Free Report) from a hold rating to a buy rating in a report published on Monday, Marketbeat reports. Maxim Group currently has $30.00 price target on the stock. Vistagen Therapeutics Stock Down 43.1 % Shares of Vistagen Therapeutics stock traded down $5.63 on Monday, reaching $7.42. […]

Blackrock incVistagen therapeutics incRenaissance technologiesMaxim groupVistagen therapeuticsFree reportTherapeutics stock downStreet corpSigma investmentsTwo sigma advisersGet free reportVistagen therapeutics dailyNasdaq vtgn

InvestorNewsBreaks — Vistagen Therapeutics Inc (NASDAQ: VTGN) Schedules Release of Q1 2024 Numbers, Corporate Update Conference Call

InvestorNewsBreaks — Vistagen Therapeutics Inc (NASDAQ: VTGN) Schedules Release of Q1 2024 Numbers, Corporate Update Conference Call
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesLos angelesTherapeutics incVistagen therapeuticsBlvd suite

Vistagen Therapeutics (VTGN) Set to Announce Quarterly Earnings on Thursday

Vistagen Therapeutics (NASDAQ:VTGN – Get Free Report) will announce its earnings results after the market closes on Thursday, August 10th. Vistagen Therapeutics Price Performance Shares of VTGN stock traded down $0.02 on Wednesday, hitting $7.40. 5,328,907 shares of the stock traded hands, compared to its average volume of 644,803. The company has a market capitalization […]

Vistagen therapeutics incBlackrock incGeode capital managementDeutsche bankMaxim groupVistagen therapeuticsGet free reportStreet corpCapital managementVistagen therapeutics dailyNasdaq vtgn

Insider Buying: Vistagen Therapeutics, Inc (NASDAQ:VTGN) Major Shareholder Buys 775,756 Shares of Stock

Vistagen Therapeutics, Inc. (NASDAQ:VTGN – Get Free Report) major shareholder Commodore Capital Lp purchased 775,756 shares of the firm’s stock in a transaction that occurred on Monday, August 7th. The stock was bought at an average cost of $23.15 per share, for a total transaction of $17,958,751.40. Following the purchase, the insider now owns 1,575,000 […]

Vistagen therapeutics incMorgan stanleySecurities exchange commissionVistagen therapeutics company profileMaxim groupAllspring global investments holdingsHenrickson nauta wealth advisors incDeutsche bankVistagen therapeuticsGet free reportExchange commissionTherapeutics stock downNauta wealth advisorsGlobal investments holdingsVistagen therapeutics dailyNasdaq vtgn

vimarsana © 2020. All Rights Reserved.